Cash & equivalents increased 425.2%
Cash & equivalents changed +425.2% from the comparable as-filed period.
$226.0M→$1.2B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CLX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Selling, general & administrative decreased 14.2%
Selling, general & administrative changed -14.2% from the comparable as-filed period.
$267.0M→$229.0M3 prior comparisons
Gross margin moved 137 bp lower
Gross margin changed -137 basis points from the comparable as-filed period.
44.60%→43.23%3 prior comparisons
Inventory decreased 7.4%
Inventory changed -7.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$635.0M→$588.0M4 prior comparisons
Gross profit decreased 3.0%
Gross profit changed -3.0% from the comparable as-filed period.
$744.0M→$722.0M3 prior comparisons
Net income increased 0.5%
Net income changed +0.5% from the comparable as-filed period.
$186.0M→$187.0M3 prior comparisons
Research & development unchangedd 0.0%
Research & development changed +0.0% from the comparable as-filed period.
$27.0M→$27.0M3 prior comparisons
Revenue increased 0.1%
Revenue changed +0.1% from the comparable as-filed period.
$1.7B→$1.7B3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.